Company profile
Alpha Cognition Inc
NASDAQ: ACOG · Healthcare · Biotechnology
PublicHQ Grapevine, BCCIK 0001655923Reports USD
#631 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
39DFH 55DQ 15GM —SS 42
v0.1 · 55/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$10.8M
Rev growth YoY (TTM)
+269.6%
Net income (FY)
-$20.7M
Employees
71
as of 2026-08-14
Market cap
$134.0M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$10.2M$10.2M2025
Net income-$20.7M-$20.7M2025
Operating income-$22.7M-$22.7M2025
Total assets$79.7M$79.7M2025
Liabilities$17.2M$17.2M2025
Equity$62.5M$62.5M2025
Revenue by segment
Filed disclosures · FY2025
By product
Service100%
By geography
UNITED STATES66%
CHINA34%
The read
What is Alpha Cognition Inc’s revenue?
Alpha Cognition Inc booked $10.2M in FY2025 revenue, contracting 90% year over year — slower than 90% of Healthcare companies we track, at a -202.2% net margin.
Peers · Healthcare
HealthWarehouse.com, Inc.——XOMA Royalty Corp.75B+TScan Therapeutics, Inc.39DKhiron Life Sciences Corp.——Zenas BioPharma, Inc.33DJanux Therapeutics, Inc.54DKey facts
CEOMichael E. McFadden
SectorHealthcare
IndustryBiotechnology
HeadquartersGrapevine, BC
ExchangeNASDAQ: ACOG
Employees71
IPO date2024-11-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.